pyrazinamide has been researched along with Lupus Erythematosus, Systemic in 7 studies
pyrazinecarboxamide : A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of pyrazinoic acid (pyrazine-2-carboxylic acid) with ammonia. A prodrug for pyrazinoic acid, pyrazinecarboxamide is used as part of multidrug regimens for the treatment of tuberculosis.
Lupus Erythematosus, Systemic: A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Due to these findings systemic lupus erythematosus (SLE) was suspected." | 1.27 | [Tuberculostatics-induced systemic lupus erythematosus]. ( Engelhard, M; Layer, P, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Martinez-Longoria, CA | 1 |
| Rubio-Perez, NE | 1 |
| Rios-Solis, JE | 1 |
| Garcia-Rodriguez, F | 1 |
| Ko, JH | 1 |
| Shih, YC | 1 |
| Huang, YH | 1 |
| Lu, CF | 1 |
| Yang, CH | 1 |
| Luzi, G | 1 |
| Diamanti, AP | 1 |
| Germano, V | 1 |
| Laganà , B | 1 |
| Di Rosa, R | 1 |
| Salemi, S | 1 |
| Stoppacciaro, A | 1 |
| D'Amelio, R | 1 |
| Bodokh, I | 1 |
| Lacour, JP | 1 |
| Costa, I | 1 |
| Botcazou, V | 1 |
| Chichmanian, RM | 1 |
| Ortonne, JP | 1 |
| Singh, S | 1 |
| Singh, YN | 1 |
| Malaviya, AN | 1 |
| Layer, P | 1 |
| Engelhard, M | 1 |
| Hart, FD | 1 |
7 other studies available for pyrazinamide and Lupus Erythematosus, Systemic
| Article | Year |
|---|---|
Severe meningoencephalitis co-infection due to Cryptococcus neoformans and Mycobacterium tuberculosis in a child with systemic lupus erythematosus.
Topics: Amphotericin B; Antitubercular Agents; Child; Coinfection; Cryptococcosis; Cryptococcus neoformans; | 2015 |
Acute tuberculosis cutis miliaris disseminata in a patient with systemic lupus erythematosus.
Topics: Acute Disease; Antitubercular Agents; Drug Combinations; Female; Humans; Isoniazid; Lupus Erythemato | 2011 |
Successful treatment with intravenous immunoglobulins in a patient affected by dermatomyositis/systemic lupus erythematosus overlap syndrome and tuberculosis.
Topics: Antitubercular Agents; Dermatomyositis; Female; Humans; Immunoglobulins, Intravenous; Immunologic Fa | 2007 |
[Aseptic meningitis during pyrazinamide therapy for lupus erythematosus].
Topics: Adult; Female; Humans; Lupus Erythematosus, Systemic; Meningitis, Aseptic; Pyrazinamide | 1993 |
Tubercular colitis in a patient with systemic lupus erythematosus: diagnosis by stool examination.
Topics: Adrenal Cortex Hormones; Adult; Colitis; Drug Therapy, Combination; Ethambutol; Feces; Female; Human | 1992 |
[Tuberculostatics-induced systemic lupus erythematosus].
Topics: Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Lupus Eryth | 1986 |
Drug-induced arthritis.
Topics: Acute Disease; Anticoagulants; Antihypertensive Agents; Arteritis; Arthritis; Barbiturates; Contrace | 1974 |